Vertex Pharmaceuticals Inc
DUS:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
DUS:VX1
|
US |
|
S
|
Siltronic AG
SWB:WAF
|
DE |
|
Imugene Ltd
F:ILA
|
AU |
|
C
|
China Vered Financial Holding Corporation Ltd
F:HKQ3
|
HK |
|
C
|
Compass Group PLC
OTC:CMPGY
|
UK |
|
Pintec Technology Holdings Ltd
NASDAQ:JF
|
CN |
|
Cisco Systems Inc
NASDAQ:CSCO
|
US |
|
T
|
Tokyo Gas Co Ltd
F:TOG
|
JP |
|
E
|
Expeditors International of Washington Inc
F:EW1
|
US |
|
N
|
Newmont Corporation
XMUN:NMM
|
US |
|
N
|
Navient Corp
SWB:10D
|
US |
|
C
|
Costco Wholesale Corp
XHAM:CTO
|
US |
|
Sony Group Corp
TSE:6758
|
JP |
|
Lufax Holding Ltd
F:0VU0
|
CN |
|
A
|
Aristocrat Leisure Ltd
SWB:AC8
|
AU |
|
B
|
BlackRock Inc
XBER:BLQA
|
US |
|
I
|
IQVIA Holdings Inc
SWB:QTS
|
US |
|
Bluestone Resources Inc
OTC:BBSRF
|
CA |
Shareholder Yield
Current shareholder yield for 
VX1 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
VX1 Price
Vertex Pharmaceuticals Inc
| Average Annual Return | 22.75% |
| Standard Deviation of Annual Returns | 18.35% |
| Max Drawdown | -35% |
| Market Capitalization | 109.2B EUR |
| Shares Outstanding | 119 157 455 |
| Percentage of Shares Shorted |
N/A
|
